Navigation Links
Pharmacyclics Reports First Quarter 2013 Results
Date:5/1/2013

132012AssetsCash, cash equivalents and marketable securities 1

$
511,247$
317,114Other current assets 2

21,41629,378Total current assets

532,663346,492Property and equipment, net

9,4786,403Other assets

3,0202,234Total assets

$
545,161$
355,129Liabilities and Stockholders' EquityDeferred revenue - current portion

$
8,036$
8,139Other current liabilities

39,35321,118Total current liabilities

47,38929,257Deferred revenue - non-current portion

59,87962,562Deferred rent

783784Total liabilities

108,05192,603Stockholders' equity

437,110262,526Total liabilities and stockholders' equity

$
545,161$
355,1291 Marketable securities

$
8,721$
9,6812 As of March 31, 2013 and December 31, 2012, Other current assets includes $17.1 million and $26.6 million, respectively, due to the Company from Janssen under the collaboration and license agreement.

Pharmacyclics, Inc.Condensed Consolidated Statements of Operations
(unaudited; in thousands, except per share data)

Three Months EndedMar. 31,Mar. 31,20132012Revenue:  License and milestone revenue

$
-$
-  Collaboration services revenue

2,8461,927Total revenue

2,8461,927Operating expenses*:  Research and Development

35,78415,828  General and Administrative

20,0264,061Total operating expenses

55,81019,889Loss from operations

(52,964)(17,962)Interest and other income, net

7956Loss before income taxes

(52,885)(17,906)Income tax benefit

9745,083Net loss

$
(51,911)$
(12,823)Net loss per share:Basic

$
(0.73)$
(0.19)Diluted

$

'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
2. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
3. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
4. Pharmacyclics, Inc. Prices Public Offering of Common Stock
5. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
6. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
7. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
8. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
9. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
10. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
11. Hospira Reports First-Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  iMD Companies, Inc. (ICBU) has repositioned ... market share and grab a foothold in the hydroponic, hemp ... capabilities and a presence in the sector, and recently partnering ... growth of hemp and medical marijuana, iMD is committing to ...
(Date:1/23/2015)... Jan. 23, 2015 Cord Blood America, Inc. ( www.cordblood-america.com ... the "Company")  filed a Preliminary Proxy Statement, Schedule 14A, with ... and provides an update for shareholders detailing why a "YES" ... Dear Shareholders, As we reflect upon ...
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ ... its CytoSorb® extracorporeal cytokine adsorber to reduce deadly ... the receipt of $385,642, net of transaction costs, ... the Technology Business Tax Certificate Transfer Program sponsored ...
Breaking Medicine Technology:iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
... June 16, 2011 Reportlinker.com announces that a ... catalogue: US Wound Closure Devices ... http://www.reportlinker.com/p0555195/US-Wound-Closure-Devices-–-Market-Trend-Till-2016.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment Short Description ... market data on the wound closure devices in ...
... 16, 2011 IDenta Corp. (Pink Sheets: IDTA ) ... marketing agreement in Japan with AOYAKA Trading Co. ( ... Mr. Shoham stated, "Japan is a very large and ... is a very tough market, it is not easy to penetrate ...
Cached Medicine Technology:Reportlinker Adds US Wound Closure Devices - Market Trend Till 2016 2International Drug & Explosives Detection Company IDenta Corp. Announces New Representative in Japan 2
(Date:1/22/2015)... Lynchburg, Va. (PRWEB) January 22, 2015 Liberty ... Health Counseling (M.A.) program from the Council for ... The program, part of Liberty’s Center for Counseling & ... Hawkins, founding dean of the university’s new School of Behavioral ...
(Date:1/22/2015)... The City of West Hollywood hosted a news conference on Thursday, ... of the Supreme Court decision Roe v. Wade, which legalized abortion ... Roe vs. Wade decision and the fight to protect a women’s ... of West Hollywood Councilmember Abbe Land. “We need to continue to ...
(Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce the release of ... kids with cancer. The Chemo Duck App, available on iTunes for ... games to help children of all ages living with cancer adjust ... kids entertained, educated and at ease while waiting for clinic visits ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who ... are thrilled to have it lead the wedding dress industry ... of prom dresses for the global market. , “The CEO ... and he focuses on continuing the goal of operational excellence ...
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company offering ... follow it on Facebook, Twitter, and Pinterest. The fans will ... draws a lottery every week. , Moreover, the company has ... Click Angelweddingdress homepage for more information. , ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2
... TUESDAY, Nov. 29 (HealthDay News) -- Among families with ... pay more out of their pockets than those without ... a new study finds. "Even when you are ... covering chronic conditions spent more out of pocket than ...
... of London suggests that many cases of diabetes could be ... study, published today in the British Medical Journal *, ... with reasonable accuracy who will develop diabetes but almost none ... these tools were used by GPs and members of the ...
... HealthDay Reporter , MONDAY, Nov. 28 (HealthDay News) -- Boys ... brains than other children, a new study finds. The ... newborns. However, at age 4 to 6 months, boys who ... have significantly larger heads than other kids, according to the ...
... (DTI) to study the effects of soccer ,heading, researchers have ... have brain abnormalities similar to those found in traumatic brain ... at the annual meeting of the Radiological Society of North ... soccer ball with their head, is an essential part of ...
... Therapeutics, the U.S. subsidiary of the international pharmaceutical group, ... U.S. market, the first and only oral solution medical ... body and found in the brain. Taken for ... or traumatic brain injury (TBI), CerAxon Oral Solution provides ...
... (HealthDay News) --,Women over 50 have more complications -- particularly ... a new study says. The higher rate of complications ... hormone levels, according to the researchers. They looked at ... 2009 and found that the post-surgery infection rate for women ...
Cached Medicine News:Health News:Chronic Disease May Up Out-of-Pocket Costs for Insured 2Health News:Tools for predicting diabetes exist but are not used, research shows 2Health News:Head Size Tied to Regressive Autism in Boys 2Health News:Head Size Tied to Regressive Autism in Boys 3Health News:'Heading' a soccer ball could lead to brain injury 2Health News:Introducing CerAxon Oral Solution 2Health News:Introducing CerAxon Oral Solution 3Health News:Older Women Have More Post-Surgical Breast Reduction Infections 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: